Solid Tumors Clinical Trials

A listing of Solid Tumors medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2048 clinical trials
Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer

biomarkers for predicting treatment efficacy. Tumor microenvironment as pivotal components of solid tumor, significantly influences therapeutic response and clinical outcome. The study is a multi-center

  • 0 views
  • 27 Apr, 2022
  • 1 location
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma

progressive functional impairment not reversible by conventional nutritional support. It is estimated to occur in over 75% of patients with advanced PDAC, the highest incidence of all solid tumors, and

  • 0 views
  • 09 Jul, 2022
  • 1 location
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

between paclitaxel drug exposure and the development of neuropathic symptoms. This trial studies if paclitaxel can be consistently measured in the blood of patients with solid tumors undergoing

therapeutic drug monitoring
paclitaxel
invasive breast cancer
doxorubicin
gemcitabine
  • 0 views
  • 06 May, 2022
  • 1 location
Remote Monitoring in Cancer Care: A Platform Study

This study investigates a device that closely monitors vital signs, as well as a smartphone application (app) that allows patients to respond to different questions and tests that will monitor for new symptoms. This study may help researchers understand if wearing the device is a better tool than standard vital …

cancer
  • 0 views
  • 21 Mar, 2022
  • 1 location
Evaluating Patient Reported Outcomes in Radiation Therapy, The PRO-RT Study

This study explores the use of the Hugo platform to involve study participants in their healthcare and treatments. The Hugo platform may allow researchers to collect better and more accurate real-time health data, from other clinics/hospitals, pharmacies and other electronic devices. The purpose of this research is to see if …

  • 0 views
  • 05 May, 2022
  • 1 location
Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. (PROTONBIOMARKS)

This trial is a paucicentric, clinico-biological cohort study with retrospective and prospective enrollment, aiming to identify biomarkers predictive of response to Proton Beam Therapy (PBT) in cancer patients (high grade sarcoma, brain tumors and meningioma). This study include collection of clinical data, of tumor samples (collected during standard of care) …

measurable disease
proton therapy
tumor cells
eosin
meningioma
  • 0 views
  • 11 Aug, 2022
  • 2 locations
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

The Marathon of Hope Cancer Centres Network (MOHCCN) is a national network of cancer centres that pursue collaborative cancer research in precision medicine (an emerging approach for disease treatment and prevention that considers individual variability in DNA, environment and lifestyle) to accelerate the discovery of innovations and improve the health …

solid tumor
precision medicine
cancer
  • 0 views
  • 15 Jun, 2022
  • 1 location
A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL

with solid tumors that have achieved significant clinical efficacy.Due to the high side effects of high-dose decitabine, patient tolerance is poor. Therefore, the purpose of this study was to evaluate

  • 0 views
  • 22 Jan, 2021
  • 1 location
RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

addition, RFA of other solid tumors is a commonly performed procedure in the United states and all RFA devices, including the device that we will use for the clinical care of these patients, are cleared by

  • 0 views
  • 21 Mar, 2022
  • 1 location
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

the STICI01 trial (NCT03453892) will be validated in the groups of patient suffering from HNSCC (palliative), NSCLC (separately palliative and adjuvant) and "other solid tumors" (including in

programmed cell death 1 ligand 1
immunomodulator
programmed cell death protein 1
solid tumour
  • 0 views
  • 28 May, 2021
  • 1 location